As GLP-1 receptor agonists, these peptide drugs mimic the incretin hormone GLP-1, enhancing glucose-dependent insulin secretion, suppressing glucagon release, delaying gastric emptying, and reducing appetite [9]
If plateau persists despite dose escalation and lifestyle optimization, compound switching offers a fresh mechanism of action
The recommended duration based on clinical guidance ranges from 4 to 8 weeks of complete discontinuation
The result is fewer drinking moments, more alternation between alcoholic and non-alcoholic choices within the same occasion, and a premium on products that deliver satisfaction with less volume
Acting on GLP-1 and GIP receptors, retatrutide promotes delayed gastric emptying and sends hunger-reducing signals to the brain
Weve really been working towards educating providers, first of all, about recognizing that and learning how to talk to and work with patients to really destigmatize the whole weight piece, Reid says